C84.7 Category · further specificity required Anaplastic large cell lymphoma, ALK-negative
ICD-10-CM C84.7 identifies “Anaplastic large cell lymphoma, ALK-negative” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Excludes 11
primary cutaneous CD30-positive T-cell proliferations (C86.6-)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C84 · Mature T/NK-cell lymphomas
Excludes 11
personal history of non-Hodgkin lymphoma (Z85.72)
More specific codes
C84.70Anaplastic large cell lymphoma, ALK-negative, unspecified siteBillable / specificC84.71Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neckBillable / specificC84.72Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodesBillable / specificC84.73Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodesBillable / specificC84.74Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limbBillable / specificC84.75Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limbBillable / specificC84.76Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodesBillable / specificC84.77Anaplastic large cell lymphoma, ALK-negative, spleenBillable / specificC84.78Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sitesBillable / specificC84.79Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sitesBillable / specificC84.7AAnaplastic large cell lymphoma, ALK-negative, breastBillable / specificC84.7BAnaplastic large cell lymphoma, ALK-negative, in remissionBillable / specificOfficial index references
Official index references (1)
Lymphoma(of) (malignant) (1)
References from other codes (1)
Excludes 1 · anaplastic large cell lymphoma, ALK negative (C84.7-)
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Anaplastic large cell lymphoma, ALK-negative
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.